Home » Newsletters » BioWorld Asia

BioWorld Asia

May 20, 1998

View Archived Issues

Herpes Protein May Boost Gene Therapy Delivery Systems

Flamel Generates $10M To Support Drug Delivery

Theratechnologies Signs Major Alliance With Genetix

British Biotech's McCullagh To Resign Amid Controversy

Biota Shares Jump On FDA Filing

European Parliament Approves Stronger Patent Protections

Wellcome Counters Efforts In US To Control Genome Discoveries

Biotech International Gets Control Of Agen In A$18M Takeover

Vanguard On Track With Migraine Drug Despite Loss Of SmithKline

Phytopharm Begins Phase II For Osteoarthritis Treatment

Dendritic Cell Exosomes Function As Vaccine Vectors

Icon IPO Generates US$50M For Clinical Trial Services

Xenova Takes Anti-MDR Therapy Into Phase I Cancer Trials

Scotia Founder Departs In Dispute With New CEO

Cortecs Signs Glaxo Deal For Macritonin In Greece

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...